2D co-culture |
Highly scalable and amenable to rapid interrogation of cellular, transcriptional, genetic, and signaling mechanisms |
Unable to match the 3D physiological complexity associated with other in-vitro systems |
In-silico |
Large computational power enables highly scalable predictive modeling of biological processes and drug responses. |
Non-biological platform and dependent on input from accurate biological datasets to establish a useful predictive model |
Microfluidic organ and body chips |
More accurate mimic of in vivo physiological forces than traditional 2D cell culture. Integrates the concept of systemic vasculature through microfluidic channels. Simultaneous interrogation of multiple cell types in a fully-integrated system. |
Modest scalability, expensive, and necessary to find appropriate biocompatible materials for cell culture |
Tissue engineering and 3D printing |
Three-dimensionality enables more realistic mimicking of in vivo tissues with potential functional uses for human transplantation |
Less scalable than traditional monoculture and cost of bioprinting and bioengineering platforms can be a limiting factor. Biocompatible bioinks must be further refined. |
Organoids and assembloids |
More realistically mimic in vivo developmental processes in an in vitro setting while retaining moderate scalability |
Maximum size is limited without adequate vascularization. Potential for tissue necrosis within organoid interior. |
Humanized animals and chimeras |
A physiologically relevant in vivo platform for studying development and potentially serving as a system for mass producing human tissues for transplantation purposes |
Expensive and limited throughput. Significant bioethical concerns with growing human reproductive, neural, and other tissues in animals. |